These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 5735367)
1. LL-AV290, a new antibiotic. II. Antibacterial efficacy in mice and in vitro. Redin GS; Dornbush AC Antimicrob Agents Chemother (Bethesda); 1968; 8():246-8. PubMed ID: 5735367 [No Abstract] [Full Text] [Related]
2. [Evaluation of antibiotic activity. Clinical evaluation of data obtained in vitro from antibiograms]. Giunchi G Antibiotica; 1966 Sep; 4(3):149-68. PubMed ID: 5991414 [No Abstract] [Full Text] [Related]
3. [Antibacterial properties of lincomycin in vitro and its chemotherapeutic activity]. Shorin VA; Pevzner NS Antibiotiki; 1968 Sep; 13(9):810-5. PubMed ID: 4387685 [No Abstract] [Full Text] [Related]
4. Enduracidin, a new antibiotic. 3. In vitro and in vivo antimicrobial activity. Tsuchiya K; Kondo M; Oishi T; Yamazaki I J Antibiot (Tokyo); 1968 Feb; 21(2):147-53. PubMed ID: 4386300 [No Abstract] [Full Text] [Related]
6. Cephaloridine. II. The effect of cephaloridine on experimental model infections. Hejzlar M; Výmola F; Paroubek M; Bdinkova H; Majorová J; Hájková L; Janovská D J Hyg Epidemiol Microbiol Immunol; 1967; 11(4):459-68. PubMed ID: 5629908 [No Abstract] [Full Text] [Related]
7. [Infectious endocarditis 100 years after Osler]. Fernández-Guerrero ML Enferm Infecc Microbiol Clin; 1996; 14(6):377-83. PubMed ID: 8756217 [No Abstract] [Full Text] [Related]
10. [Bacteriological studies on the treatment of surgical infections with Framycetin]. Weber HG Med Klin; 1965 Oct; 60(40):1624-8. PubMed ID: 5882502 [No Abstract] [Full Text] [Related]
11. Antibiotic treatment of streptococcal, enterococcal, and staphylococcal endocarditis. Working Party of the British Society for Antimicrobial Chemotherapy. Working P Heart; 1998 Feb; 79(2):207-10. PubMed ID: 9538323 [No Abstract] [Full Text] [Related]
15. [Value of quantitative bacteriological examination of sputum in the evaluation of the effectiveness of chemotherapy of bacterial respiratory tract infections. II. Clinical studies]. Nikodemowicz E; Owsiński J; Przybyłkiewicz Z; Kasprowicz A; Maternowska W; Kamińska M; Walaszek K; Prus F Pneumonol Pol; 1980 Aug; 48(8):545-22. PubMed ID: 6968434 [No Abstract] [Full Text] [Related]
17. Maridomycin, a new macrolide antibiotic. 3. In vitro and in vivo antibacterial activity. Kondo M; Oishi T; Ishifuji K; Tsuchiya K J Antibiot (Tokyo); 1973 Apr; 26(4):206-14. PubMed ID: 4782049 [No Abstract] [Full Text] [Related]
18. [Experimental study of the antibacterial activity and chemotherapeutic efficacy of the novel glycopeptide eremomycin]. Malikova IV Antibiot Khimioter; 1989 Jan; 34(1):52-6. PubMed ID: 2543344 [TBL] [Abstract][Full Text] [Related]
19. [Value of quantitative bacteriological examination of sputum in the evaluation of the effectiveness of chemotherapy of bacterial respiratory tract infections. I. Bacteriological studies]. Przybyłkiewicz Z; Nikodemowicz E; Kasprowicz A; Owsiński J Pneumonol Pol; 1980 Aug; 48(8):535-43. PubMed ID: 6775309 [No Abstract] [Full Text] [Related]
20. Clinical outcome of pneumococcal bacteremia, in vitro resistance, and antibiotic therapy. Torres-Tortosa M; Caballero-Granado J; Canueto J; Moreno-Maqueda I Clin Infect Dis; 2004 Mar; 38(5):763-4; author reply 765-6. PubMed ID: 14986265 [No Abstract] [Full Text] [Related] [Next] [New Search]